EASL-EASD-EASO Clinical practice guidelines for the management of nonalcoholic fatty liver disease: is universal screening appropriate?

by Byrne, C., Targher, G.
Published 2016

Gallstone disease and increased risk of ischemic heart disease: causal association or epiphenomenon?

by Targher, G., Byrne, Christopher D.
Published 2015

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes

by Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., Byrne, Christopher D.
Published 2013

Epidemiological modifiers of non-alcoholic fatty liver disease: focus on high-risk groups

by Lonardo, A., Bellentani, S., Argo, C.K, Ballestri, S., Byrne, Christopher D., Caldwell, S.H, Cortez-Pinto, H., Grieco, A., Machado, M.V, Miele, L., Targher, G.
Published 2015

Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease

by Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Valbusa, F., Bertolini, L., Zenari, L., Pichiri, I., Dauriz, M., Zoppini, G., Barbieri, E., Byrne, Christopher D., Bonora, E., Targher, G.
Published 2015